Authors
Latest:
Prescription Drug Monitoring Programs Benefit PharmacistsHow PDMPs are helping both patients and pharmacists.
Latest:
Rivaroxaban for inherited thrombophilia: A case studyIs rivaroxaban the best therapeutic option for this patient?
Latest:
Rivaroxaban for inherited thrombophilia: A case studyIs rivaroxaban the best therapeutic option for this patient?
Latest:
Rivaroxaban for inherited thrombophilia: A case studyIs rivaroxaban the best therapeutic option for this patient?
Latest:
Rivaroxaban for inherited thrombophilia: A case studyIs rivaroxaban the best therapeutic option for this patient?
Latest:
Job tips for pharmacy grads, 2015Looking for that first pharmacy job? Here are a few things to keep in mind.
Latest:
Edoxaban approved to prevent AF stroke and treat VTEEdoxaban is an oral factor Xa inhibitor that prevents thrombin generation and platelet aggregation, and therefore thrombus formation.
Latest:
Cost vs. value: Healthcare shifts its focusValue-based care is transforming the world of healthcare. Simple cost management must give way to utilization management, and alignment of stakeholder services is inevitable.
Latest:
Pharmacists and unionization: It’s later than you thinkPharmacists need to unionize. You've heard all the reasons. Here's another one -- and it's time-sensitive.
Latest:
Pharmacists on the frontline of preventive healthcare servicesFor patients, preventive services are a vital healthcare resource. For the healthcare delivery system, they produce cost savings. Pharmacists are a key link.
Latest:
FDA approves ceftazidime-avibactam to treat two complicated infectionsThe combination product is indicated to treat either complicated intra-abdominal infections, where it is used in combination with metronidazole, or complicated urinary tract infections in patients with few or no other treatment options.
Latest:
Pharmaceuticals and pharmaphobesIt can take years to establish the safety and efficacy of new drug therapies. What should we do in the meantime?
Latest:
15 keys to the New PharmacyIn Part 3 of "The New Pharmacy," Mark Burger takes you through the daily checklist of a successful practice.
Latest:
The market side of biosimilarsR&D and product manufacture are only the beginning. When the time comes to enter the marketplace, biosimilars still face numerous obstacles.
Latest:
FDA approves PAH treatmentSelexipag is a first-in-class oral treatment option to reduce progression and hospitalization for pulmonary arterial hypertension.
Latest:
Sterile compounding: Regulations, best practices, and industry standardsWhere things stand, where they're headed, and what you need to do now.
Latest:
“Pharmacists, lobby your legislators!” says BOP insiderIf you want improved working conditions in the pharmacy, you're gonna hafta help.
Latest:
How pharmacists should be fighting the heroin epidemicOnce we as individuals in the healthcare profession finally begin to accept addiction as a disease and not a moral failing, the affected individuals will have a better chance at recovery and we will gain a better understanding of this epidemic.
Latest:
Pharmacy of tomorrowTomorrow's pharmacists and pharmacies will need to find ways to increase profit margins by reducing the cost of prescribing, embracing technology, and focusing more on patient counseling, immunizations, education, and other offshoots of their clinical expertise.
